Skip to main content
. 2014 Jun 28;33(9):1247–1254. doi: 10.1007/s10067-014-2711-2

Table 2.

Hazard ratios for discontinuation of the three drugs due to specific causes

Etanercept Tocilizumab Abatacept
(reference) HR (95 % CI) HR (95 % CI)
All unfavorable causes 1 0.58 (0.13–2.66) 1.21 (0.33–4.51)
Inadequate efficacy 1 1.37 (0.12–15.29) 2.14 (0.21–21.57)
Adverse events 1 0.28 (0.27–2.82) 0.77 (0.13–4.42)

Adjusted by sex, age, concomitant use of methotrexate, disease duration, and clinical disease activity index

HR hazard ratio, CI confidence interval